World Sleep Day 2026: Global Study Finds Nearly 1 in 4 People at Risk of Sleep Apnea
A global study of Samsung Health users released for World Sleep Day found that 23% of participants showed signs of sleep apnea risk, with the condition silently robbing sufferers of deep sleep and REM sleep every night.
Epilepsy Drug Cuts Sleep Apnea Breathing Interruptions by Nearly 50% in Clinical Trial
A large European clinical trial found that sulthiame, an existing epilepsy medication, reduced breathing interruptions during sleep by up to 47% in patients with moderate to severe obstructive sleep apnea, raising hopes for a pharmaceutical alternative to CPAP therapy.
More Than 1 in 4 Teens May Experience Sleep Paralysis, New Research Suggests
Research by a 17-year-old student recognized in the Regeneron Science Talent Search found that over 25% of surveyed high school students reported symptoms of sleep paralysis, a rate consistent with studies of college-aged populations and raising questions about the role stress plays.
Online Program Helps Older Adults Overcome Insomnia When In-Person Therapy Is Out of Reach
A clinical trial of more than 300 participants found that SHUTi OASIS, the first digital insomnia program designed specifically for adults over 55, produced sleep improvements that lasted at least a year—two to three times better than standard online education.
Multiple Sclerosis Patients Twice as Likely to Develop Restless Legs Syndrome, Study Finds
A study from Spain found that people with multiple sclerosis are about twice as likely to develop restless legs syndrome as those without the disease, with family history and pyramidal symptoms increasing the risk further.
Smartphones May Hold Key to Measuring Insomnia Treatment Success, Study Finds
A new study suggests that tracking daytime symptoms like fatigue and mood through smartphone apps may be more effective than traditional sleep diaries for determining whether insomnia medications are working.
First Oral Pill for Sleep Apnea Nears FDA Approval After Successful Trial
Pharmaceutical company Apnimed plans to file for FDA approval of AD109 in early 2026 after the drug met its primary endpoint in a second Phase 3 trial, potentially offering relief to patients who struggle with CPAP therapy.
Scientists Inch Closer to Understanding Why Some People Sleepwalk
While scientists have made strides in understanding sleepwalking and night terrors, including finding that familial cases start earlier and are more severe, the fundamental question of why some people develop these behaviors remains unanswered.
Sleeping Less Than 7 Hours Could Shorten Your Life More Than Poor Diet, Study Finds
A new study from Oregon Health & Science University found that regularly getting less than seven hours of sleep is more strongly associated with shorter lifespan than poor diet, lack of exercise or social isolation.